CV Sciences (CVSI) Times Interest Earned (2011 - 2026)
CV Sciences (CVSI) reported Times Interest Earned of -$3.42 for Q1 2026, down 4793.84% on a YoY basis from $0.07 in Q1 2025, and down 1841.59% sequentially from $0.2 in Q4 2025.
CV Sciences (CVSI) Times Interest Earned (2011 - 2026) Analysis & Trends
CV Sciences (CVSI) has 16 years of Times Interest Earned data on file, last reported at -$3.42 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned fell 4793.84% year-over-year to -$3.42; the trailing twelve-month figure through Mar 2026 stood at $18.16 (up 519.32% YoY), and the FY2025 full-year result was -$0.04, up 78.19% from the prior year.
- Times Interest Earned retreated to -$3.42 in Q1 2026, from $0.2 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $19.21 in Q1 2023 to a low of -$6.87 in Q4 2024.
- A 5-year average of -$0.68 and a median of -$2.2 in 2023 frame the typical range for Times Interest Earned.
- Across the five-year window, Times Interest Earned jumped 860.66% in 2023 and sank 13059.49% in 2024, its largest moves.
- Tracing CVSI's Times Interest Earned over 5 years: stood at -$2.52 in 2022, then surged by 97.93% to -$0.05 in 2023, then slumped by 13059.49% to -$6.87 in 2024, then soared by 102.86% to $0.2 in 2025, then plunged by 1841.59% to -$3.42 in 2026.
- Business Quant data shows CVSI's Times Interest Earned at -$3.42 in Q1 2026, $0.2 in Q4 2025, and -$0.63 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | CV Sciences | 3.74 Mn | 3.43 Mn | 1.56 Mn | -3.42 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.42 |
| Dec 31, 2025 | 0.20 |
| Sep 30, 2025 | -0.63 |
| Jun 30, 2025 | -0.26 |
| Mar 31, 2025 | 0.07 |
| Dec 31, 2024 | -6.87 |
| Sep 30, 2024 | -2.97 |
| Jun 30, 2024 | -2.53 |
| Mar 31, 2024 | -3.78 |
| Dec 31, 2023 | -0.05 |
| Sep 30, 2023 | -1.88 |
| Jun 30, 2023 | -4.05 |
| Mar 31, 2023 | 19.21 |
| Mar 31, 2022 | -2.53 |
| Dec 31, 2021 | -0.49 |
| Sep 30, 2021 | -58.43 |
| Jun 30, 2021 | -9.29 |
| Mar 31, 2021 | -1.56 |
| Sep 30, 2020 | -0.61 |
| Jun 30, 2020 | -0.87 |